Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]

View source ↗

Summary

This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple myeloma, DLBCL, ALL, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Diffuse Large B-cell Lymphoma
• Multiple Myeloma
• T-cell Lymphoma

Drugs mentioned

• AUTO CAR T Cell Therapy (autologous CAR T cells)

Snippet

Sponsor: Autolus Limited | Conditions: Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma | Phase 2 | Status: ENROLLING_BY_INVITATION